Announcements Trials
Browse Landscape

Status

Completed 6Unknown 1Terminated 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 5Rectal Neoplasms 4Lymphoma, Large-Cell, Immunoblastic 4Colonic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Burkitt Lymphoma 3Breast Neoplasms 3Wilms Tumor 2Testicular Neoplasms 2Sezary Syndrome 2Recurrence 2Primary Myelofibrosis 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Neuroblastoma 2Neoplasms 2Myeloproliferative Disorders 2Mycosis Fungoides 2Multiple Myeloma 2Lymphoma, T-Cell, Cutaneous 2Lymphoma 2Leukemia, Neutrophilic, Chronic 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

Carboplatin 49Pemetrexed 38Cisplatin 34Radiotherapy 32Docetaxel 31Gemcitabine 25Paclitaxel 24Nivolumab 18pembrolizumab 15Etoposide 15Radiosurgery 13Erlotinib Hydrochloride 11Bevacizumab 11Magnetic Resonance Spectroscopy 10Vinorelbine 9Radiation 9Cyclophosphamide 7Gefitinib 6Fluorodeoxyglucose F18 6Celecoxib 6durvalumab 5atezolizumab 5Oxaliplatin 5Irinotecan 5Immunoglobulin G 5Drug Therapy 5Disulfides 5Dexamethasone 5Chemotherapy, Adjuvant 5vandetanib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Lung Neoplasms × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT01567722 2023-03-16

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

AIDS Malignancy Consortium

Terminated
114 enrolled 8 charts
LymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Lymphoma, HIV Infections, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡